COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,236 Articles (22,227 medRxiv, 8,009 bioRxiv)

Most recent first Previous |  Page 1094: Articles 10931-10940  | Next

Higher Hospitalization and Mortality Rates Among SARS-CoV-2 infected Persons in Rural America
Anzalone, A. J., Horswell, R., Hendricks, B., Chu, S., Hillegass, W., Beasley, W., Harper, J., Rosen, C., Miele, L., McClay, J., Santangelo, S., Hodder, S., N3C Consortium
10.1101/2021.10.05.21264543 — Posted: 2021-10-07 Discussion: Onsite
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty COVID-19 vaccine
Gimenez, E., Alberola, J., Torres, I., Albert, E., Alcaraz, M. J., Botija, P., Amat, P., Remigia, M. J., Beltran, M. J., Rodado, C., Huntley, D., Olea, B., Navarro, D.
10.1101/2021.10.06.21264616 — Posted: 2021-10-07 Discussion: Onsite
Analytical performance of eleven SARS-CoV-2 antigen-detecting rapid tests for Delta variant
Bekliz, M., Adea, K., Essaidi-Laziosi, M., Escadafal, C., Sacks, J., Kaiser, L., Eckerle, I.
10.1101/2021.10.06.21264535 — Posted: 2021-10-07
Predicting increases in COVID-19 incidence to identify locations for targeted testing in West Virginia: A machine learning enhanced approach
Price, B. S., Khodaverdi, M., Halasz, A., Hendricks, B., Kimble, W., Smith, G. S., Hodder, S. L.
10.1101/2021.10.06.21264569 — Posted: 2021-10-07
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness
Liu, C., Lee, J., Ta, C., Soroush, A., Rogers, J. R., Kim, J. H., Natarajan, K., Zucker, J., Weng, C.
10.1101/2021.10.05.21264583 — Posted: 2021-10-07
Genetic risk factors and Covid-19 severity in Brazil: results from BRACOVID Study
Pereira, A., Bes, T. M., Velho, M., Marques, E., Jannes, C., Ramos Valino, K., Dinardo, C. M., Costa, S. F., Duarte, A. J., Santos, A. R., Mitne-Neto, M., Pestana, J. M., Krieger, J. E.
10.1101/2021.10.06.21264631 — Posted: 2021-10-07
Effect of workplace infection control practices on workers' psychological distress: a large-scale cohort study during the COVID-19 second state of emergency in Japan
Kodama, T., Ishimaru, T., Tateishi, S., Hino, A., Tsuji, M., OGami, A., Nagata, T., Matsuda, S., Fujino, Y.
10.1101/2021.10.05.21264597 — Posted: 2021-10-07
Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis
Qu, W., Wang, Z., Cook, E. E., Siddik, A. B., Bu, G., Allickson, J. G., Kubrova, E., Caplan, A. I., Hare, J. M., Ricordi, C., Pepine, C. J., Kurtzberg, J., Pascual, J. M., Mallea, J. M., Rodriguez, R. L., Nayfeh, T., Saadi, S., Richards, E. M., March, K., Sanfilippo, F. P.
10.1101/2021.10.05.21264559 — Posted: 2021-10-07
Minority and Rural Coronavirus Insights Study (MRCIS): The Need for Targeted COVID-19 Vaccination Efforts in Minority Populations
Landry, L., Lee, L., Meyer, W., Puckrein, G., Chalasani, N., Xu, L., Stair, T., Wiltz, G., Sampson, M., Gregerson, P., Barron, C., Marable, J., Akinboboye, O.
10.1101/2021.10.06.21264407 — Posted: 2021-10-07
Inactivated Poliovirus Vaccine Induces Antibodies that Inhibit RNA Synthesis of SARS-CoV-2: An open-label, pre-post vaccine clinical trial
Comunale, B. A., Jackson-Ward, E., Jiang, Y., Ward, L. P., Liu, Q., Ji, L., Lai, M., Comunale, R. A., Engineer, L., Xie, Q.
10.1101/2021.10.05.21264598 — Posted: 2021-10-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).